Short Bowel Syndrome Market Size And Share

Report Code : TIPRE00011653
Category : Life Sciences

No. of Pages : 150

Buy Now

Principales conclusions et analyse des parts de marché du syndrome de l'intestin court d'ici 2025-2031

Buy Now

Short Bowel Syndrome Market Report Analysis

Short Bowel Syndrome Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Takeda Pharmaceutical Company Limited
Zealand Pharma A/S
VectivBio AG
9 Meters Biopharma, Inc
Hanmi Pharm.Co.,Ltd
GlaxoSmithKline, Plc
Cadila Pharmaceuticals
Sun Pharmaceutical Industries Ltd
Troikaa

Regional Overview

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et centrale
Moyen-Orient et Afrique

Market Segmentation

By Classe de médicaments

peptide de type glucagon
bloqueurs H2
inhibiteurs de la pompe à protons
autres

By Canal de distribution

pharmacies hospitalières
pharmacies de détail
vente en ligne

By Géographie

Amérique du Nord
Europe
Asie-Pacifique
Amérique du Sud et Centrale